Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein

被引:35
作者
Batool, Asiya [1 ]
Aashaq, Sabreena [1 ]
Andrabi, Khurshid I. [1 ]
机构
[1] Univ Kashmir, Dept Biotechnol & Bioinformat, Srinagar, Jammu & Kashmir, India
关键词
eIF4E; Mnk; mTOR; translation; tumorigenesis; INTERACTING KINASE 1; MESSENGER-RNA; DEPENDENT TRANSLATION; CELL-GROWTH; ANTISENSE OLIGONUCLEOTIDE; THERAPEUTIC TARGET; MAMMALIAN TARGET; CLINICAL-TRIAL; BREAST-CANCER; P-BODIES;
D O I
10.1002/jcb.28851
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic initiation factor 4E (eIF4E), a fundamental effector and rate limiting element of protein synthesis, binds the 7-methylguanosine cap at the 5 ' end of eukaryotic messenger RNA (mRNA) specifically as a constituent of eIF4F translation initiation complex thus facilitating the recruitment of mRNA to the ribosomes. This review focusses on the engagement of signals contributing to growth factor originated maxim and their role in the activation of eIF4E to achieve a collective influence on cellular growth, with a key focus on conjuring vital processes like protein synthesis. The review invites considerable interest in elevating the appeal of eIF4E beyond its role in regulating translation viz a viz cancer genesis, attributed to its phosphorylation state that improves the prospect for the growth of the cancerous cell. This review highlights the latest studies that have envisioned to target these pathways and ultimately the translational machinery for therapeutic intervention. The review also brings forward the prospect of eIF4E to act as a converging juncture for signaling pathways like mTOR/PI3K and Mnk/MAPK to promote tumorigenesis.
引用
收藏
页码:14201 / 14212
页数:12
相关论文
共 108 条
[1]   Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway [J].
Adesso, L. ;
Calabretta, S. ;
Barbagallo, F. ;
Capurso, G. ;
Pilozzi, E. ;
Geremia, R. ;
Delle Fave, G. ;
Sette, C. .
ONCOGENE, 2013, 32 (23) :2848-2857
[2]   Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors [J].
Altman, Jessica K. ;
Szilard, Amy ;
Konicek, Bruce W. ;
Iversen, Philip W. ;
Kroczynska, Barbara ;
Glaser, Heather ;
Sassano, Antonella ;
Vakana, Eliza ;
Graff, Jeremy R. ;
Platanias, Leonidas C. .
BLOOD, 2013, 121 (18) :3675-3681
[3]   Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E [J].
Andrieu, C. ;
Taieb, D. ;
Baylot, V. ;
Ettinger, S. ;
Soubeyran, P. ;
De-Thonel, A. ;
Nelson, C. ;
Garrido, C. ;
So, A. ;
Fazli, L. ;
Bladou, F. ;
Gleave, M. ;
Iovanna, J. L. ;
Rocchi, P. .
ONCOGENE, 2010, 29 (13) :1883-1896
[4]  
[Anonymous], J ONCOL
[5]   mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix [J].
Asimomytis, Aristidis ;
Karanikou, Maria ;
Rodolakis, Alexander ;
Vaiopoulou, Anna ;
Tsetsa, Paraskevi ;
Creatsas, George ;
Stefos, Theodoros ;
Antsaklis, Aristidis ;
Patsouris, Efstratios ;
Rassidakis, George Z. .
ONCOLOGY LETTERS, 2016, 12 (05) :3234-3240
[6]   Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin [J].
Assouline, Sarit ;
Culjkovic, Biljana ;
Cocolakis, Eftihia ;
Rousseau, Caroline ;
Beslu, Nathalie ;
Amri, Abdellatif ;
Caplan, Stephen ;
Leber, Brian ;
Roy, Denis-Claude ;
Miller, Wilson H., Jr. ;
Borden, Katherine L. B. .
BLOOD, 2009, 114 (02) :257-260
[7]   MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition [J].
Astanehe, A. ;
Finkbeiner, M. R. ;
Krzywinski, M. ;
Fotovati, A. ;
Dhillon, J. ;
Berquin, I. M. ;
Mills, G. B. ;
Marra, M. A. ;
Dunn, S. E. .
ONCOGENE, 2012, 31 (41) :4434-4446
[8]   Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].
Avdulov, S ;
Li, S ;
Michalek, V ;
Burrichter, D ;
Peterson, M ;
Perlman, DM ;
Manivel, JC ;
Sonenberg, N ;
Yee, D ;
Bitterman, PB ;
Polunovsky, VA .
CANCER CELL, 2004, 5 (06) :553-563
[9]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[10]  
Barbera JPM, 2000, DEVELOPMENT, V127, P2433